Nanobiosym Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 10

Nanobiosym General Information

Description

Developer of a nanotechnology platform designed to create scientific insights and transformational technologies. The company's platform emerges from the integration of physics, biomedicine, and nanotechnology to detect genetic fingerprints from any biological organism, enabling people to have affordable and portable diagnostic information about their own health.

Contact Information

Website
www.nanobiosym.com
Formerly Known As
Nanobiosym Research Institute
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Other Healthcare Technology Systems
Corporate Office
  • 245 First Street
  • 18th Floor
  • Cambridge, MA 02142
  • United States
+1 (781) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanobiosym Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 18-Mar-2019 Completed Generating Revenue
5. Later Stage VC 25-Apr-2017 Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Grant 07-Jul-2015 00000 Completed Generating Revenue
2. Angel (individual) 26-Feb-2015 Completed Generating Revenue
1. Grant 12-Dec-2013 $1.25M Completed Generating Revenue
To view Nanobiosym’s complete valuation and funding history, request access »

Nanobiosym Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a nanotechnology platform designed to create scientific insights and transformational technologies. The com
Biotechnology
Cambridge, MA
11 As of 2023
0000000000 0

000000

exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
0000000000000
Louisville, CO
000 As of 0000
00000
000000000 00000

000000

te velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cu
00000 0000000000 000
Cambridge, MA
00 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanobiosym Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biodesix Formerly VC-backed Louisville, CO 000 00000 000000000 00000
Ultivue Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
You’re viewing 2 of 2 competitors. Get the full list »

Nanobiosym Patents

  • 50

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 32

    Granted

  • 9

    Pending

  • 000

    Expiring in next 12 mo

Nanobiosym Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210308677-A1 Systems and methods for mobile device analysis of nucleic acids and proteins Pending 15-Mar-2013 000000000000
US-10933417-B2 Systems and methods for mobile device analysis of nucleic acids and proteins Active 15-Mar-2013 000000000000 000
US-20140335527-A1 Systems and methods for mobile device analysis of nucleic acids and proteins Active 15-Mar-2013 000000000000 0
CA-3158087-A1 Systems and methods for mobile device analysis of nucleic acids and proteins Pending 15-Mar-2013 000000000000
CA-2906728-A1 Systems and methods for mobile device analysis of nucleic acids and proteins Active 15-Mar-2013 B01L7/52
To view Nanobiosym’s complete patent history, request access »

Nanobiosym Executive Team (7)

Name Title Board Seat Contact Info
Anita Goel Ph.D Founder, Chief Executive Officer, Chairman, President & Scientific Director
Homi Mullan Advisor
Paul Maritz Advisor
Ratan Tata Advisor
Robert Langer Ph.D Advisor
You’re viewing 5 of 7 executive team members. Get the full list »

Nanobiosym Board Members (1)

Name Representing Role Since
Anita Goel Ph.D Nanobiosym Founder, Chief Executive Officer, Chairman, President & Scientific Director 000 0000
To view Nanobiosym’s complete board members history, request access »

Nanobiosym Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanobiosym Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Integro Cap Venture Capital Minority 000 0000 000000 0
Unreasonable Group Accelerator/Incubator Minority 000 0000 000000 0
Crown Holding Growth/Expansion Minority 000 0000 000000 0
Massachusetts Life Sciences Center Government 000 0000 000000 0
Paul Maritz Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Nanobiosym FAQs

  • When was Nanobiosym founded?

    Nanobiosym was founded in 2004.

  • Who is the founder of Nanobiosym?

    Anita Goel Ph.D is the founder of Nanobiosym.

  • Who is the CEO of Nanobiosym?

    Anita Goel Ph.D is the CEO of Nanobiosym.

  • Where is Nanobiosym headquartered?

    Nanobiosym is headquartered in Cambridge, MA.

  • What is the size of Nanobiosym?

    Nanobiosym has 11 total employees.

  • What industry is Nanobiosym in?

    Nanobiosym’s primary industry is Biotechnology.

  • Is Nanobiosym a private or public company?

    Nanobiosym is a Private company.

  • What is Nanobiosym’s current revenue?

    The current revenue for Nanobiosym is 000000.

  • Who are Nanobiosym’s investors?

    Integro Cap, Unreasonable Group, Crown Holding, Massachusetts Life Sciences Center, and Paul Maritz are 5 of 10 investors who have invested in Nanobiosym.

  • Who are Nanobiosym’s competitors?

    Biodesix and Ultivue are competitors of Nanobiosym.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »